News for 'diabetes'

Gurugram Busts Racket Making Fake Diabetes Injections

Gurugram Busts Racket Making Fake Diabetes Injections

Rediff.com21 Apr 2026

Authorities in Gurugram have uncovered a racket involved in the manufacturing and sale of fake Mounjaro (tirzepatide) injections, used for treating diabetes and obesity. Two people have been arrested, and a nationwide alert has been issued to trace counterfeit batches.

Gurugram Police Uncover Fake Diabetes Injection Racket

Gurugram Police Uncover Fake Diabetes Injection Racket

Rediff.com21 Apr 2026

Authorities in Gurugram have uncovered a racket involving the manufacturing and sale of counterfeit Mounjaro (tirzepatide) injections, used for treating type 2 diabetes and aiding weight loss. Two individuals have been arrested, and a nationwide alert has been issued to detect the fake injections.

Gurugram Police Uncover Fake Diabetes Drug Racket

Gurugram Police Uncover Fake Diabetes Drug Racket

Rediff.com20 Apr 2026

Authorities in Gurugram have uncovered a racket involving the manufacturing and sale of counterfeit Mounjaro (tirzepatide) injections, used for treating type 2 diabetes and aiding weight loss, leading to the arrest of two individuals and a nationwide alert.

Think Tank Calls For Probe Into Fake Diabetes Drug Racket

Think Tank Calls For Probe Into Fake Diabetes Drug Racket

Rediff.com22 Apr 2026

An independent think tank on policing has called for a multi-agency investigation into the recent unearthing of a spurious Mounjaro (tirzepatide) injection manufacturing racket in Gurugram, offering free-of-cost forensic expertise.

Study: Smartwatch Data Offers Scalable Way to Detect Early Diabetes Risk

Study: Smartwatch Data Offers Scalable Way to Detect Early Diabetes Risk

Rediff.com18 Mar 2026

A new study reveals a framework using smartwatch data to detect early signs of diabetes by predicting insulin resistance, potentially enabling timely lifestyle interventions.

Diabetics Can Eat Fruits But....

Diabetics Can Eat Fruits But....

Rediff.com16 Jan 2026

rediffGURU Komal Jethmalani, a nutritionist with nearly three decades of experience, suggests how to make the right diet and lifestyle choices to keep blood sugar under check.

Inside Alexander Zverev's quiet battle with diabetes

Inside Alexander Zverev's quiet battle with diabetes

Rediff.com26 Jan 2026

As he chases Grand Slam success, Alexander Zverev describes the unseen routines and discipline behind playing tennis with type 1 diabetes.

Experts question relying solely on HbA1c for diabetes test

Experts question relying solely on HbA1c for diabetes test

Rediff.com10 Feb 2026

Researchers are cautioning against relying solely on glycated haemoglobin (HbA1c) for diagnosing and monitoring diabetes in South Asia, especially India, due to the high prevalence of anaemia and blood disorders that can complicate the interpretation of values.

Want To Be A Mounjaro Bride: Is It Worth It?

Want To Be A Mounjaro Bride: Is It Worth It?

Rediff.com5 days ago

'Don't chase unrealistic expectations or compare yourself to social media transformations.' 'Focus on your health first, not just the number on the scale before the wedding.'

AIIMS Delhi Achieves Rare Pancreas-Kidney Transplant After 18 Years

AIIMS Delhi Achieves Rare Pancreas-Kidney Transplant After 18 Years

Rediff.com13 May 2026

Doctors at AIIMS, Delhi, have successfully performed a simultaneous pancreas-kidney transplant after 18 years, marking a significant advancement in organ transplantation in India. The surgery was performed on a 30-year-old patient with end-stage renal disease caused by Type 1 diabetes.

Canada first G7 nation to okay Dr Reddy's generic version of semaglutide

Canada first G7 nation to okay Dr Reddy's generic version of semaglutide

Rediff.com30 Apr 2026

Dr Reddy's Laboratories has received approval from Health Canada to sell a generic version of the diabetes drug semaglutide, making it the first company to get market authorisation for a generic semaglutide injection in Canada and the first in a G7 country.

Weight Loss Drugs Sales Surge!

Weight Loss Drugs Sales Surge!

Rediff.com16 May 2026

'The innovators have been able to more or less stay where they are, in terms of revenue even as the generics are seeing exponential growth due to their affordability.'

Biocon launches diabetes & obesity drugs in Netherlands

Biocon launches diabetes & obesity drugs in Netherlands

Rediff.com16 Dec 2025

Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as the biopharmaceutical firm positions itself as a global player in the fast-growing diabetes and obesity market currently dominated by the likes of Novo Nordisk and Eli Lilly.

Belagavi Court Remands Ponzi Scheme Accused To Custody

Belagavi Court Remands Ponzi Scheme Accused To Custody

Rediff.com18 May 2026

A Belagavi court has remanded Shivaanand Neelannavar, the alleged kingpin of a multi-crore ponzi scheme, to 10 days of CID custody for further investigation. The case involves an alleged fraud of nearly Rs 1,000 crore and affects around 35,000 investors.

Thousands Of Weight Loss Injections Seized In Gurugram

Thousands Of Weight Loss Injections Seized In Gurugram

Rediff.com19 Apr 2026

A vehicle carrying thousands of weight loss and diabetes injections was seized in Gurugram during a raid by the Drug Control Department.

Weight Loss Drugs May Alter Your Brain

Weight Loss Drugs May Alter Your Brain

Rediff.com12 May 2026

A new study suggests that newer oral weight loss drugs may do more than suppress appetite, potentially altering brain circuits that control motivation and reward, impacting how one experiences pleasure.

10 Things That Originated In India

10 Things That Originated In India

Rediff.com21 May 2026

Do you know some of the thoughts, ideas, disciplines and items India has given the world?

Slimming Drug Boom Sparks Misuse Concerns: 'They Are Not Meant For Cosmetic Weight Loss'

Slimming Drug Boom Sparks Misuse Concerns: 'They Are Not Meant For Cosmetic Weight Loss'

Rediff.com20 Apr 2026

The fast-growing GLP-1 market, propelled by lower-cost generics following patent expiry, is widening availability beyond patients with obesity and diabetes -- but also driving unsupervised, appearance-led demand, according to doctors.

'No Such Thing As Diabetes Reversal'

'No Such Thing As Diabetes Reversal'

Rediff.com14 Nov 2025

'In diabetes remission, you go below a 6.5 HbA1c without medication.' 'And this happens only when you lose 10 to 15 per cent of your body weight with a good amount of lifestyle and dietary changes, exercise and sometimes medication.' 'You have to be able to sustain your HBA1C below 6.5 for at least a year without medication to say that the patient is in remission.'

Silent Diseases Hit Young India

Silent Diseases Hit Young India

Rediff.com16 Apr 2026

Young adults show alarming NCD trends, with high rates of obesity, prediabetes, and abnormal cholesterol levels.

Biocon eyes global insulin leadership as rivals pivot to GLP-1 therapies

Biocon eyes global insulin leadership as rivals pivot to GLP-1 therapies

Rediff.com8 Apr 2026

Biocon aims to become the world's leading insulin company, capitalising on larger pharmaceutical rivals' strategic shift towards newer, high-margin GLP-1 diabetes therapies. The company plans to expand its insulin presence across 80 markets, focusing on value maximisation and addressing the indispensable need for insulin, particularly for Type-1 and late-stage Type-2 diabetics.

'My Father-In-Law's Death Saved Our Marriage'

'My Father-In-Law's Death Saved Our Marriage'

Rediff.com21 May 2026

Chitra tells us how her strained relationship with her husband and mother-in-law gradually improved after her father-in-law passed away.

Murder Accused Allegedly Dies By Suicide In Jabalpur Jail

Murder Accused Allegedly Dies By Suicide In Jabalpur Jail

Rediff.com20 Apr 2026

A 60-year-old murder accused allegedly committed suicide inside a jail in Jabalpur, Madhya Pradesh, on Monday morning. The undertrial prisoner, Guddu alias Raja Vishwakarma, allegedly hanged himself using a towel in the bathroom of a hospital ward in the prison where he was being treated.

PCOS Is Now PMOS: Why This Change Matters

PCOS Is Now PMOS: Why This Change Matters

Rediff.com14 May 2026

PCOS is being renamed PMOS. Dr Anagha Menon breaks down why the one alphabet change matters and how it affects the diagnosis of this condition for so many women.

Hypertension in Army ranks at 9.61%, below national levels: Govt

Hypertension in Army ranks at 9.61%, below national levels: Govt

Rediff.com1 Apr 2026

A parliamentary panel has been informed that the prevalence of hypertension among Indian Army's junior commissioned officers and other ranks is lower than the national average, according to data up to December 31, 2023.

'Every Other Person Could Have Diabetes'

'Every Other Person Could Have Diabetes'

Rediff.com12 Nov 2025

'One in two people tested shows high blood sugar levels.' '51.9 per cent of men and 45.43 per cent of women who tested had high blood sugar.'

Indian Pharma Market Records Strongest Q4 Growth in Five Quarters

Indian Pharma Market Records Strongest Q4 Growth in Five Quarters

Rediff.com9 Apr 2026

India's domestic pharmaceutical market recorded its highest value growth in five quarters during Q4 FY26, driven primarily by pricing and an early indication of volume recovery, with a significant structural shift towards chronic and sub-chronic therapies.

Biocon eyes in-licensing to boost biosimilars portfolio, targets margin expansion

Biocon eyes in-licensing to boost biosimilars portfolio, targets margin expansion

Rediff.com9 May 2026

Biocon is actively seeking in-licensing opportunities to expand its biosimilars portfolio, focusing on products that complement existing therapy areas, as the company shifts to a 'consolidate' phase with a strong emphasis on improving capacity utilisation, expanding margins, and driving return on capital employed.

Avoid These Life Insurance Mistakes

Avoid These Life Insurance Mistakes

Rediff.com8 May 2026

Proposal forms are often filled by the agent. Check the form after it is filled.

Pune Firm Unveils Diabetes-Control Implant

Pune Firm Unveils Diabetes-Control Implant

Rediff.com19 Nov 2025

This innovation works by stimulating our natural organs so that it can produce and maintain the insulin balance.

Centre Cracks Down on GLP-1 Drug Misuse

Centre Cracks Down on GLP-1 Drug Misuse

Rediff.com25 Mar 2026

Inspections conducted across 49 entities including pharmacies, wholesalers, and clinics to detect violations and misleading marketing practices.

Can Skipping Breakfast Make You Diabetic?

Can Skipping Breakfast Make You Diabetic?

Rediff.com16 Oct 2025

Skipping breakfast can lead to insulin resistance and overeating later, warns rediffGURU Komal Jethmalani, a nutritionist with over 26 years of experience.

Obesity Drug Can't Be Advertised Anymore

Obesity Drug Can't Be Advertised Anymore

Rediff.com12 Mar 2026

'Any promotional activity carried out under the pretext of disease awareness, influencer engagement, corporate campaigns, or similar activities that create brand recall/product visibility of the prescription shall also be treated as violations.'

Semaglutide Ruling Sparks Generic Pharma Boom

Semaglutide Ruling Sparks Generic Pharma Boom

Rediff.com24 Mar 2026

At the heart of this debate is Section 3(d) of the Patents Act, a safeguard designed to prevent drugmakers from extending monopoly protection through trivial modifications to existing medicines.

Heart Disease Risk Calculators Inadequate for Indian Population, Study Finds

Heart Disease Risk Calculators Inadequate for Indian Population, Study Finds

Rediff.com4 Apr 2026

A new study reveals that widely used heart disease risk calculators may not accurately identify Indians at risk, potentially leading to underestimation of risk and delayed treatment.

Fake Life-Saving Drugs Racket Busted in Delhi

Fake Life-Saving Drugs Racket Busted in Delhi

Rediff.com5 Apr 2026

Delhi Police have dismantled an organised interstate racket involved in manufacturing and distributing counterfeit life-saving medicines, arresting six individuals and seizing fake drugs worth approximately Rs 2 crore. The investigation also revealed a network of fake GST firms used for generating bogus invoices and laundering money.

Why Shiv Sena MP Milind Deora Is Against Weight-Loss Drugs

Why Shiv Sena MP Milind Deora Is Against Weight-Loss Drugs

Rediff.com9 Apr 2026

'The unregulated marketing has to stop. People are getting recommendations for this from gym trainers, from marriage counsellors -- that is simply unacceptable.' ''There are many ways to lose weight -- eat less, fast, exercise, eat healthy. That is how you lose weight.'

Delhi Man Shot Dead Over Parking Row: How It Happened

Delhi Man Shot Dead Over Parking Row: How It Happened

Rediff.com20 Apr 2026

A man was shot dead in Delhi's Preet Vihar following a parking dispute with a neighbour. The incident has left his pregnant wife and family in mourning.

Abbott Bets On Semaglutide Boom

Abbott Bets On Semaglutide Boom

Rediff.com28 Feb 2026

Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.

Court Allows Lalu Aide Amit Katyal to Travel, Modifies Bail Terms in Money Laundering Case

Court Allows Lalu Aide Amit Katyal to Travel, Modifies Bail Terms in Money Laundering Case

Rediff.com16 Apr 2026

A Delhi court has granted Amit Katyal, a businessman linked to Lalu Prasad's family, permission to travel for religious purposes and modified his bail conditions in a money laundering case.